Cardiovascular Risk in Growth Hormone Deficient Young Adult Males After Completing Growth Hormone Therapy

Completed

Conditions studied: Growth Hormone Deficiency

In brief

The purpose of this study is to compare the cardiovascular risks of growth hormone deficient young adult males who have completed growth hormone therapy to healthy young adult males.

Key facts

Study ID

NCT00711061

Run by

Children's Mercy Hospital Kansas City

People needed

24

Starts

2008-06-01

Expected to finish

2009-02-01

Last updated by the study team

2009-02-10

Who can join

Age: 18 and older, up to 25. Sex: male. Healthy volunteers: accepted.

You may not qualify if…

• Known risk factors for cardiovascular disease (eg tobacco use, hypertension, diabetes)
• Family history of early cardiovascular disease (myocardial infarction or stroke <55years of age) in first degree family members
• Any implanted device
• Medication known to interfere with glucose or lipid metabolism or to influence blood pressure
• Chronic organ illness (eg severe asthma, hepatic or nephritic conditions)

Where it is running

• Childrens Mercy Hospitals and Clinics — Kansas City, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.